Total Artificial Heart Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Powered by 
All the vital news, analysis, and commentary curated by our industry experts.
Total Artificial Heart Pipeline Market Report Overview
A total artificial heart is a prosthetic device that is implanted into the body to replace the biological heart. The total artificial heart pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with the trials.
| Key Territories | · The US
· Europe · China · Australia · Israel |
| Key Regulatory Paths | · PMA
· CE · NMPA · HSA · TGA |
| Leading Companies | · Abiomed Inc
· Aerospace Taixin Technology Co Ltd · BioLife4D Corp · BiVacor Pty Ltd · Carmat SAS |
| Enquire & Decide | Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase. |
Total Artificial Heart Pipeline Market Segmentation by Territories
A few of the key territories with the total artificial heart pipeline market are the US, Europe, China, Australia, and Israel. As of April 2024, the US accounted for the highest number of total artificial heart pipeline products.
Total Artificial Heart Pipeline Market Analysis by Territories, 2024 (%)
Buy the Full Report for More Territory Insights into the Total Artificial Heart Pipeline Market
Total Artificial Heart Pipeline Market Segmentation by Regulatory Paths
A few of the key regulatory paths in the total artificial heart pipeline products market are PMA, CE, NMPA, HSA, and TGA. As of April 2024, PMA was the most followed pathway for pipeline products in the total artificial heart market.
Total Artificial Heart Pipeline Market Analysis by Regulatory Paths, 2024 (%)
Buy the Full Report for More Regulatory Path Insights into the Total Artificial Heart Pipeline Market
Total Artificial Heart Pipeline Market – Competitive Landscape
A few of the key companies associated with the total artificial heart pipeline market are Abiomed Inc., Aerospace Taixin Technology Co Ltd, BioLife4D Corp, BiVacor Pty Ltd, and Carmat SAS among others.
Abiomed Inc: Abiomed is a medical device company that develops, manufactures, and markets circulatory support devices. The devices replace or assist the pumping function in a failing heart. The company’s heart support and recovery product portfolio includes Impella heart pumps and the Breathe system (implantable cardiac and respiratory assist devices). Abiomed also offers online clinical support through Impella Connect, on-call assistance, and on-site assistance for health workers in hospitals. The company sells its products through direct sales and distributors in South America, Europe, Asia, and the Middle East. Abiomed is headquartered in Danvers, Massachusetts, the US.
Carmat SAS: Carmat is a medical equipment company that provides artificial organs. The company provides the development of innovative artificial organs, artificial hearts, and other vital organs, among others. Carmat artificial heart products consist of an implantable heart. The company offers components that help connect to an electric power supply and external systems such as a power supply, monitoring, and hospital control system for the post-operative period. Carmat provides services such as wearable power supply and communication systems, besides a remote diagnosis system. The company’s product serves heart failure patients in the US and European countries. Carmat is headquartered in Paris, France.
Total Artificial Heart Pipeline Market Analysis by Companies, 2024
Buy the Full Report for More Company Insights into the Total Artificial Heart Pipeline Market
Segments Covered in the Report
Total Artificial Heart Pipeline Market Territories Outlook (2024)
- The US
- Europe
- China
- Australia
- Israel
Total Artificial Heart Pipeline Market Regulatory Paths Outlook (2024)
- PMA
- CE
- NMPA
- HSA
- TGA
Scope
This report provides:
- Extensive coverage of the total artificial heart under development.
- An exhaustive list of major pipeline products and their details, including product description, licensing and collaboration details, and other developmental activities.
- Reviews of major players involved in the development of total artificial heart and lists all their pipeline projects.
- Coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage.
- Key clinical trial data of ongoing clinical trials specific to pipeline products.
- Recent developments in the segment/industry.
Reasons to Buy
- Formulate significant competitor information, analysis, and insights to improve R&D strategies.
- Identify emerging players with potentially strong product portfolios and create effective counter strategies to gain a competitive advantage.
- Identify and understand important and diverse types of total artificial heart under development.
- Develop market-entry and market-expansion strategies.
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.
- Carry out an in-depth analysis of the product’s current stage of development, territory, and estimated launch date.
Aerospace Taixin Technology Co Ltd
BioLife4D Corp
BiVacor Pty Ltd
Carmat SAS
Cleveland Clinic Lerner College of Medicine
Cleveland Heart Inc
Collplant Biotechnologies Ltd
CoRISMA MCS Systems Inc
Foster-Miller Inc (Inactive)
Griffith University
Lausanne University Hospital
OregonHeart Inc (Inactive)
ReliantHeart, Inc.
Scandinavian Real Heart AB
Shanghai Xinhengrui Medical Technology Co Ltd
Suzhou Xinqing Medical Technology Co Ltd
Syncardia Systems LLC
University of New South Wales
University of Tokyo
Table of Contents
Table
Figures
Frequently asked questions
-
Which territory had the highest number of products in the total artificial heart pipeline market as of April 2024?
- As of April 2024, the US accounted for the highest number of pipeline products in the total artificial heart market.
-
Which was the most followed regulatory pathway in the total artificial heart pipeline market as of April 2024?
- As of April 2024, PMA was the most followed pathway for pipeline products in the total artificial heart market.
-
Which are the major companies operating in the total artificial heart pipeline market?
A few of the key companies associated with the total artificial heart pipeline market are Abiomed Inc., Aerospace Taixin Technology Co Ltd, BioLife4D Corp, BiVacor Pty Ltd, and Carmat SAS among others.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.
Sample Report
Total Artificial Heart Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:
- Assess the relevance of the report
- Evaluate the quality of the report
- Justify the cost
Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.
